Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events
- PMID: 2413616
- DOI: 10.1016/0042-6822(85)90010-8
Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events
Abstract
Early events in the infection of the human T-lymphotropic virus type-I (HTLV-I)-positive MT-4 cell line by the acquired immune deficiency syndrome (AIDS) retrovirus HTLV-III were investigated. The virus was adsorbed completely to the cells within 60 min incubation after inoculation of the virus. Then, infected MT-4 cells started to produce the HTLV-III-specific antigens between 12 and 24 hr postinfection. Synthesis of the viral antigens consisting of 120K, 46K, 24K, and 17K polypeptides was suppressed by the treatment of the virus-infected MT-4 cells with cytosine arabinoside (Ara-C) or by the treatment of the virus with anti-HTLV-III-positive sera. The progeny of the virus released from the infected MT-4 cells was titrated by a newly developed plaque-forming assay method and reverse transcriptase activity. The maximum activity of HTLV-III (3 X 10(5) PFU/ml) was observed on Days 4 and 5 p.i. Most of the viral activities in this preparation were ascribed to HTLV-III, and not to HTLV-I. No phenotypic mixing between HTLV-III and HTLV-I was discerned, although MT-4 cells were HTLV-I-producer cell line. Thus, HTLV-III-infected MT-4 cells are thought to be useful in further study of the interaction between host cells and the virus, and appear to be a good viral source for the analysis of the virus.
Similar articles
-
Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.Proc Natl Acad Sci U S A. 1986 Jun;83(12):4297-301. doi: 10.1073/pnas.83.12.4297. Proc Natl Acad Sci U S A. 1986. PMID: 2424024 Free PMC article.
-
Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.Science. 1985 Aug 9;229(4713):563-6. doi: 10.1126/science.2992081. Science. 1985. PMID: 2992081
-
Serological differences between human T-lymphotropic virus type-I (HTLV-I) and HTLV-III/LAV.Microbiol Immunol. 1986;30(6):533-44. doi: 10.1111/j.1348-0421.1986.tb02979.x. Microbiol Immunol. 1986. PMID: 3018457
-
Inhibitors of retroviral DNA polymerase: their implication in the treatment of AIDS.Cancer Res. 1985 Sep;45(9 Suppl):4677s-4684s. Cancer Res. 1985. PMID: 2410112 Review.
-
A pathogenic retrovirus (HTLV-III) linked to AIDS.N Engl J Med. 1984 Nov 15;311(20):1292-7. doi: 10.1056/NEJM198411153112006. N Engl J Med. 1984. PMID: 6208484 Review.
Cited by
-
Dysregulation of the tumor suppressor Menin and its target Bach2 in HTLV-1 infection.Retrovirology. 2025 Mar 25;22(1):3. doi: 10.1186/s12977-025-00660-7. Retrovirology. 2025. PMID: 40128849 Free PMC article.
-
Antiretroviral activity in a marine red alga: reverse transcriptase inhibition by an aqueous extract of Schizymenia pacifica.J Cancer Res Clin Oncol. 1987;113(5):413-6. doi: 10.1007/BF00390034. J Cancer Res Clin Oncol. 1987. PMID: 2442171 Free PMC article.
-
A cGAS-mediated type I interferon response in human CD4+ T cells depends on productive infection and is conserved over HIV types and strains.J Virol. 2024 Oct 22;98(10):e0087724. doi: 10.1128/jvi.00877-24. Epub 2024 Sep 13. J Virol. 2024. PMID: 39269176 Free PMC article.
-
Evaluation of ALKBH2 and ALKBH3 gene regulation in patients with adult T-cell leukemia/lymphoma.Virol J. 2024 Dec 4;21(1):316. doi: 10.1186/s12985-024-02590-w. Virol J. 2024. PMID: 39633427 Free PMC article.
-
Plaque staining assay for non- or weakly cytotoxic human immunodeficiency virus.J Clin Microbiol. 1987 Jul;25(7):1305-7. doi: 10.1128/jcm.25.7.1305-1307.1987. J Clin Microbiol. 1987. PMID: 2440907 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials